Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Both hold potential in different domains: Bitcoin as peer-to-peer money and blockchain as a platform for diverse, programmable applications.
28,588 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Fastly stock jumps 11% after a strong Q4 2025 report, fueling talk of a true comeback. Yet persistent insider selling...
Morningstar analysts warn SpaceX could be worth far less than its IPO price, focusing on profitability gaps and Starl...
Oracle shares slide as Larry Ellison funds a bid to steer a $110 billion media empire, triggering regulatory hurdles ...
Adobe is a powerhouse of creativity and marketing tech, but its stock has faced AI-driven noise. This guide breaks do...
As lawmakers push the CLARITY Act to widen the CFTC’s crypto remit, new reporting highlights internal tensions and po...
Intel shares jumped on a new Hitachi pact, fueling speculation that Google and NVIDIA could lean on Intel Foundry for...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A noticeable shift is forming in the housing market as early 2026 data show momentum building. Prices are stabilizing...
Markets can swing wildly, but your plan shouldn’t. This guide shows how to prepare for a stock market crash coming wi...
JPMorgan Chase has set a bold 7% net interest income growth goal for 2026. This article explains why the target could...
A landmark federal lawsuit against OpenAI puts AI liability in the spotlight. This article explains what it means for...